PRIM Stock Overview
PT Royal Prima Tbk provides hospital services in Indonesia.
Royal Prima Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||Rp302.00|
|52 Week High||Rp625.00|
|52 Week Low||Rp180.00|
|1 Month Change||-4.43%|
|3 Month Change||-19.25%|
|1 Year Change||65.03%|
|3 Year Change||-32.89%|
|5 Year Change||n/a|
|Change since IPO||-59.73%|
Recent News & Updates
|PRIM||ID Healthcare||ID Market|
Return vs Industry: PRIM exceeded the ID Healthcare industry which returned 14.4% over the past year.
Return vs Market: PRIM exceeded the ID Market which returned 15.6% over the past year.
|PRIM Average Weekly Movement||5.8%|
|Healthcare Industry Average Movement||5.5%|
|Market Average Movement||6.3%|
|10% most volatile stocks in ID Market||12.2%|
|10% least volatile stocks in ID Market||3.0%|
Stable Share Price: PRIM is not significantly more volatile than the rest of ID stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: PRIM's weekly volatility has decreased from 13% to 6% over the past year.
About the Company
PT Royal Prima Tbk provides hospital services in Indonesia. The company was founded in 2013 and is headquartered in Jakarta, Indonesia.
Royal Prima Fundamentals Summary
|PRIM fundamental statistics|
Is PRIM overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|PRIM income statement (TTM)|
|Cost of Revenue||Rp405.06b|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
|Earnings per share (EPS)||37.12|
|Net Profit Margin||20.34%|
How did PRIM perform over the long term?See historical performance and comparison
Is Royal Prima undervalued compared to its fair value and its price relative to the market?
Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate PRIM's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate PRIM's fair value for valuation analysis.
Price To Earnings Ratio
PE vs Industry: PRIM is good value based on its PE Ratio (8.1x) compared to the ID Healthcare industry average (20.2x).
PE vs Market: PRIM is good value based on its PE Ratio (8.1x) compared to the ID market (18.8x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate PRIM's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: PRIM is good value based on its PB Ratio (1x) compared to the ID Healthcare industry average (1.9x).
How is Royal Prima forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Royal Prima has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Royal Prima performed over the past 5 years?
Past Performance Score5/6
Past Performance Score 5/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PRIM has high quality earnings.
Growing Profit Margin: PRIM's current net profit margins (20.3%) are higher than last year (8.8%).
Past Earnings Growth Analysis
Earnings Trend: PRIM's earnings have grown significantly by 57.5% per year over the past 5 years.
Accelerating Growth: PRIM's earnings growth over the past year (594.3%) exceeds its 5-year average (57.5% per year).
Earnings vs Industry: PRIM earnings growth over the past year (594.3%) exceeded the Healthcare industry 121.6%.
Return on Equity
High ROE: PRIM's Return on Equity (12.7%) is considered low.
How is Royal Prima's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: PRIM's short term assets (IDR455.2B) exceed its short term liabilities (IDR167.1B).
Long Term Liabilities: PRIM's short term assets (IDR455.2B) exceed its long term liabilities (IDR8.3B).
Debt to Equity History and Analysis
Debt Level: PRIM is debt free.
Reducing Debt: PRIM has no debt compared to 5 years ago when its debt to equity ratio was 10.1%.
Debt Coverage: PRIM has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: PRIM has no debt, therefore coverage of interest payments is not a concern.
What is Royal Prima current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate PRIM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PRIM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if PRIM's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PRIM's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as PRIM has not reported any payouts.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Tommy Leonard (35 yo)
Dr. Tommy Leonard has been the President Director of PT Royal Prima Tbk since 2015. Dr. Leonard holds Bachelor’s Degree in Law, Dharmawangsa University (2008) Magister in Notary and Doctor of Law North Sum...
Experienced Board: PRIM's board of directors are considered experienced (7.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
PT Royal Prima Tbk's employee growth, exchange listings and data sources
- Name: PT Royal Prima Tbk
- Ticker: PRIM
- Exchange: IDX
- Founded: 2013
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: Rp895.430b
- Shares outstanding: 3.39b
- Website: https://www.royalprima.com
Number of Employees
- PT Royal Prima Tbk
- Jalan Letjen S Parman
- Kav. 22 - 24
- Jakarta Raya
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/18 00:00|
|End of Day Share Price||2022/05/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.